Bevacizumab for the treatment of recurrent glioblastoma.
作者： Marc C. Chamberlain
DOI: 10.4137/CMO.S7232
关键词:
摘要: … positive results in two prospective phase 2 studies, bevacizumab … disorders, such as radiation-induced necrosis with mass effect,… Phase II trial of the antiangiogenic agent thalidomide …
sagepub.com
sci-hub.se 参考文章(97)
M. Paldino, A. Desjardins, H. S. Friedman, J. J. Vredenburgh, D. P. Barboriak, Prognostic significance of early changes in the apparent diffusion coefficient that occurs after treatment of patients with glioblastoma multiforme with bevacizumab Journal of Clinical Oncology. ,vol. 27, pp. 2058- 2058 ,(2009) , 10.1200/JCO.2009.27.15_SUPPL.2058
M. K. Nicholas, R. V. Lucas, J. Arzbaecher, N. Paleologos, H. Krouwer, M. Malkin, A. Omar, N. A. Vick, Bevacizumab in combination with temozolomide in the adjuvant treatment of newly diagnosed glioblastoma multiforme: Preliminary results of a phase II study Journal of Clinical Oncology. ,vol. 27, pp. 2016- 2016 ,(2009) , 10.1200/JCO.2009.27.15_SUPPL.2016
Marc C. Chamberlain, Salvage chemotherapy with CPT-11 for recurrent glioblastoma multiforme Journal of Neuro-oncology. ,vol. 56, pp. 183- 188 ,(2002) , 10.1023/A:1014532202188
Eric T. Wong, Kenneth R. Hess, Mary Jo Gleason, Kurt A. Jaeckle, Athanassios P. Kyritsis, Michael D. Prados, Victor A. Levin, W.K. Alfred Yung, Outcomes and Prognostic Factors in Recurrent Glioma Patients Enrolled Onto Phase II Clinical Trials Journal of Clinical Oncology. ,vol. 17, pp. 2572- 2578 ,(1999) , 10.1200/JCO.1999.17.8.2572
Henry S. Friedman, William P. Petros, Allan H. Friedman, Larry J. Schaaf, Tracy Kerby, Jennifer Lawyer, Mary Parry, Peter J. Houghton, Shelley Lovell, Karima Rasheed, Tim Cloughsey, Elizabeth S. Stewart, O. Michael Colvin, James M. Provenzale, Roger E. McLendon, Darell D. Bigner, Ilkcan Cokgor, Michael Haglund, Jeremy Rich, David Ashley, Joseph Malczyn, Gary L. Elfring, Langdon L. Miller, Irinotecan Therapy in Adults With Recurrent or Progressive Malignant Glioma Journal of Clinical Oncology. ,vol. 17, pp. 1516- 1525 ,(1999) , 10.1200/JCO.1999.17.5.1516
Tumor Angiogenesis: A Quantitative Method for Histologic Grading Journal of the National Cancer Institute. ,vol. 48, pp. 347- 356 ,(1972) , 10.1093/JNCI/48.2.347
Howard A. Fine, William D. Figg, Kurt Jaeckle, Patrick Y. Wen, Athanassios P. Kyritsis, Jay S. Loeffler, Victor A. Levin, Peter M. Black, Richard Kaplan, James M. Pluda, W.K. Alfred Yung, Phase II Trial of the Antiangiogenic Agent Thalidomide in Patients With Recurrent High-Grade Gliomas Journal of Clinical Oncology. ,vol. 18, pp. 708- 715 ,(2000) , 10.1200/JCO.2000.18.4.708
Thomas J. Semrad, Robert O'Donnell, Ted Wun, Helen Chew, Danielle Harvey, Hong Zhou, Richard H. White, Epidemiology of venous thromboembolism in 9489 patients with malignant glioma. Journal of Neurosurgery. ,vol. 106, pp. 601- 608 ,(2007) , 10.3171/JNS.2007.106.4.601
Ricky T. Tong, Yves Boucher, Sergey V. Kozin, Frank Winkler, Daniel J. Hicklin, Rakesh K. Jain, Vascular Normalization by Vascular Endothelial Growth Factor Receptor 2 Blockade Induces a Pressure Gradient Across the Vasculature and Improves Drug Penetration in Tumors Cancer Research. ,vol. 64, pp. 3731- 3736 ,(2004) , 10.1158/0008-5472.CAN-04-0074
Rakesh K. Jain, Emmanuelle di Tomaso, Dan G. Duda, Jay S. Loeffler, A. Gregory Sorensen, Tracy T. Batchelor, Angiogenesis in brain tumours Nature Reviews Neuroscience. ,vol. 8, pp. 610- 622 ,(2007) , 10.1038/NRN2175